Vident Investment Advisory’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-12,664
| Closed | -$516K | – | 693 |
|
|
2023
Q2 | $516K | Buy |
12,664
+1,362
| +12% | +$55.5K | 0.02% | 686 |
|
|
2023
Q1 | $421K | Buy |
11,302
+4,696
| +71% | +$175K | 0.01% | 839 |
|
|
2022
Q4 | $230K | Buy |
+6,606
| New | +$230K | 0.01% | 980 |
|
|
2021
Q4 | – | Sell |
-1,628
| Closed | -$219K | – | 1227 |
|
|
2021
Q3 | $219K | Sell |
1,628
-898
| -36% | -$121K | 0.01% | 1067 |
|
|
2021
Q2 | $409K | Buy |
+2,526
| New | +$409K | 0.01% | 885 |
|